Non-Viral Gene Therapy 2011
DOI: 10.5772/18636
|View full text |Cite
|
Sign up to set email alerts
|

Peptides as Promising Non-Viral Vectors for Gene Therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 169 publications
(254 reference statements)
0
1
0
Order By: Relevance
“…CPPs offer greater stability and biocompatibility than other non-viral vectors. Despite their low molecular weight, these peptides can provide different functions such as forming complexes with nucleic acids, cell penetration, and endosomal disruption, all of which are crucial for gene delivery [ 12 - 14 , 15 ] . Studies have demonstrated that nona-arginine (R9) can non-covalently bind to siRNA and deliver it into mammalian cells [ 16 , 17 ] .…”
Section: Introductionmentioning
confidence: 99%
“…CPPs offer greater stability and biocompatibility than other non-viral vectors. Despite their low molecular weight, these peptides can provide different functions such as forming complexes with nucleic acids, cell penetration, and endosomal disruption, all of which are crucial for gene delivery [ 12 - 14 , 15 ] . Studies have demonstrated that nona-arginine (R9) can non-covalently bind to siRNA and deliver it into mammalian cells [ 16 , 17 ] .…”
Section: Introductionmentioning
confidence: 99%